INDSWFTLAB - Ind-Swift Laboratories

Ind-Swift Laboratories

INDSWFTLAB · Pharma > Pharmaceuticals & Drugs · Chairman: N R Munjal · MD: N R Munjal · Listing date: July 17, 1997 · Employees: 1531 · Chandigarh · http://www.indswiftlabs.com

Stock Price vs Company Growth

2.4%

5.1%

23.8%

17.4%

77.1%

60.7%

7.3%

10y

15.4%

all

6.4%

🤔 How to analyze this graph?

Last Traded Price

₹ 166 2.4%

127

174

Company Overview

Sales

626 Cr

Growth: -12.4%

Profit after Tax

41.4 Cr

Growth: 26.7%

Small Cap

1,447 Cr

P/E: 32.3x

Industry P/E: 31.1x

Fundamentals

Sales (Cr)	₹ 626
Growth	-12.4%
EBITDA	4.8%
P/S	2.3x
Dividend	0.0%
P/E	32.3x
Book Value	₹ 169
PEG Ratio	-2.6x
ROE	3.1%
P/B	1.0x

Shareholding Pattern

Institutions

Edelweiss India Special Situations Fund Ii

10.43 %

Ec Special Situations Fund

6.82 %

Ashokkumar Chandak

2.79 %

Eisaf Ii Onshore Fund

2.24 %

Sri Ganesh Biotech Private Limited

1.26 %

Promoters

Essix Biosciences Limited

21.71 %

Ind Swift Ltd

16.08 %

N.R. Munjal

1.56 %

Rishav Mehta

0.77 %

Himanshu Jain

0.69 %

Others

Increase Decrease No change

Company Profile Detailed

Ind-Swift Laboratories is a part of the Ind-swift Group and is based at Chandigarh, India. It has been promoted by Ind-Swift Limited in a joint venture with the Punjab State Industrial Development Corporation Limited (PSIDC). The group has established a strong reputation as innovators in the Indian pharmaceutical industry. Ind-Swift Laboratories Ltd. went public in 1997 and concentrated on the manufacturing of Active Pharmaceutical Ingredients (API).

Investors (118)

eisaf.ii...

share.in...

neha.ver...

Followers (1)

murali5